Cancer Center of Sun Yat-sen University (Cancer Hospital Affiliated to Sun Yat-sen University) is one of the bases of oncology with large scale and strong academic strength, which integrates medical treatment, teaching, scientific research and prevention. The center was jointly established by the former "South China Cancer Hospital" established by 1964 and the former Cancer Institute of Sun Yat-sen Medical College, which realized the close combination of clinical diagnosis and treatment and basic research. The older generation experts of the Center, such as Liang, Li, Guan, Qu Baoxiang, Pan Qichao, Min Huaqing and Liao Yueqin, have made outstanding contributions in domestic academic circles. Their rigorous scientific spirit of doing research and caring for the wounded and dying have accumulated excellent cultural traditions in our hospital, inspiring generations of scholars to struggle endlessly. Oncology in our center became a key discipline in Guangdong Province from 65438 to 0999, and 200 1 was rated as a national key discipline. In the same year, the first clinical trial research base of anti-tumor drugs (GCP Center) in China was established. In 2005, he was awarded the State Key Laboratory of Oncology in South China. The center is also the WHO Collaborating Center for Cancer Research. In 2003, it became a sister hospital with the famous M.D.Anderson Cancer Center in the United States, and also cooperated and exchanged with advanced cancer prevention institutions in the world such as Sweden, Japan, France and Britain. In April 2009, the center was upgraded to a deputy department level unit, and the upgraded cancer prevention and treatment center was set up with 7 functional departments and 27 business departments. From June 5438 to February 2009, the underground radiotherapy center of Sun Yat-sen University Cancer Center was built, becoming the largest radiotherapy center in Asia. At the end of 20 10, the center became the "Guangdong provincial cancer standardized diagnosis and treatment guidance center". 201February, 10, South China Biotherapy Base was officially listed in our center. The center has 534 employees/kloc-0, including 240 senior titles, 2 academicians of China Academy of Sciences, 48 doctoral supervisors, 97 master supervisors and more than 400 graduate students. Master's and doctor's enrollment majors: oncology, imaging medicine and nuclear medicine, anesthesiology and molecular medicine. At present, the patients admitted to the center come from all over the country and Southeast Asia, and there are currently 1072 beds. In 2065,438+00, the number of outpatients exceeded 400,000, the number of discharged patients was about 38,000, and more than 7,800 cases were operated. The medical business volume ranks in the forefront of national cancer hospitals, and it has unparalleled advantages in disease resources used for clinical research. In, there were more than 654.38+00000 new tumor cases in the province, accounting for 20% of the new tumor cases in the province. It is equipped with nasopharynx, head and neck, chest, colorectal, stomach and pancreas, hepatobiliary, gynecology, urology, neurology, internal medicine, radiotherapy, imaging and minimally invasive intervention, traditional Chinese medicine, endoscopic laser, biotherapy, breast, children's tumor, hematology, nuclear medicine, pathology and laboratory (including blood bank). The main medical equipment includes PET/CT, 64-slice spiral CT and